Integra LifeSciences IART Business Segments
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| Total Revenues by Product | ||||||
| ENT | $165.28M-0.7% | $166.37M+0.8% | $165.1M+0.2% | $164.82M+0.1% | $164.65M+21.4% | |
| Instruments | $202.76M-1.8% | $206.47M+0.6% | $205.21M-2.0% | $209.3M-0.7% | $210.75M+3.2% | |
| Neurosurgery | $834.95M+0.9% | $827.67M+0.7% | $821.56M+3.2% | $795.95M+0.4% | $792.46M-1.4% | |
| Private Label | $113.17M+1.7% | $111.25M+4.9% | $106.06M-3.7% | $110.16M-1.6% | $111.98M-3.7% | |
| Wound Reconstruction | $328.36M+1.5% | $323.49M-6.2% | $345.05M+1.0% | $341.52M-0.9% | $344.47M-1.7% | |
| Total Revenues by Geography | ||||||
| Asia Pacific | $189.36M+0.1% | $189.25M+5.4% | $179.58M+3.2% | $173.96M+1.0% | $172.17M-2.5% | |
| Europe | $167.3M+2.9% | $162.67M0.0% | $162.66M+5.5% | $154.13M+1.3% | $152.23M-4.0% | |
| Rest of World | $75.94M-3.4% | $78.58M-2.2% | $80.33M+1.8% | $78.91M-2.9% | $81.25M-1.8% | |
| United States | $1.21B+0.6% | $1.2B-1.3% | $1.22B+0.5% | $1.21B-0.3% | $1.22B+2.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Integra LifeSciences break its business down?
- Integra LifeSciences (IART) reports total revenues by business across 2 parts — Specialty Surgery and Tissue Reconstruction. Each is extracted from the segment footnotes and tracked over time.
- Where does Integra LifeSciences's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Integra LifeSciences's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
